KRYS vs AMGN: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Amgen Inc in 2026
KRYS
Krystal Biotech Inc
$270.00
AMGN
Amgen Inc
$350.95
Key Metrics Comparison
| Metric | KRYS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $7.87B | $188.58B | AMGN |
| P/E Ratio | 39.04 | 24.57 | AMGN |
| EPS (TTM) | $6.85 | $14.24 | AMGN |
| Revenue Growth | 0.2% | 0.1% | KRYS |
| Gross Margin | 94.1% | 70.8% | KRYS |
Analyze KRYS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or AMGN a better investment?
Comparing KRYS and AMGN: Krystal Biotech Inc has a market cap of $7.87B while Amgen Inc has $188.58B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and AMGN?
KRYS (Krystal Biotech Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or AMGN?
Based on P/E ratios, AMGN trades at a lower multiple (24.6x vs 39.0x).
Which is growing faster: KRYS or AMGN?
KRYS has higher revenue growth at 0.2% vs 0.1% for AMGN.
Which company is more profitable: KRYS or AMGN?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 70.8% for AMGN.
Which is the larger company: KRYS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.58B compared to $7.87B for KRYS.
Should I buy KRYS or AMGN in 2026?
Both KRYS and AMGN have investment merit. KRYS trades at $270.00 while AMGN trades at $350.95. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and AMGN stock?
Key differences: Market Cap ($7.87B vs $188.58B), P/E Ratio (39.0x vs 24.6x), Revenue Growth (0.2% vs 0.1%), Gross Margin (94.1% vs 70.8%).